Compounds / Anabolic / Drostanolone Propionate

Drostanolone Propionate

Drostanolone Propionate (Masteron — DHT-Derived Anabolic Steroid)

AnabolicFDA: Previously FDA-approved breast cancer...WADA: PROHIBITED — Category S1

Overview

FDA-approved historically for inoperable breast cancer in women (withdrawn — replaced by better options). Limited modern human research. Anti-estrogenic mechanism studied in hormone-sensitive cancer context.

Mechanism of Action

2α-methyl DHT derivative. Does not aromatize (DHT-based). Anti-estrogenic properties via competitive aromatase binding. Moderate anabolic, moderate androgenic. Originally developed as breast cancer treatment — antiestrogen properties studied in ER+ breast cancer.

Molecular Profile

Molecular weight

360.5 Da

CAS number

521-12-0

Key Research Findings

No aromatization; anti-estrogenic; DHT derivative; FDA-approved historical breast cancer; limited modern human data.

Published Research

Eur J Cancer (1977)

Trams G. Effect of drostanolone propionate on binding of oestradiol and dihydrotestosterone by target tissues

View source

Related Anabolic Compounds

Testosterone Cypionate Testosterone Enanthate Testosterone Propionate Testosterone Suspension Sustanon (Testosterone Blend)Nandrolone Decanoate

Clinical Guidance

Research data is not a treatment plan. If you are considering Drostanolone Propionate, the questions that matter are whether it suits your history, your labs and your goals. That is a conversation with a licensed physician, not a lookup.

Speak with a physician LATOM Wellness is a physician-led telehealth practice. Consultation only. No compound is sold on this site.

Running Drostanolone Propionate? Log doses and track your cycle.

Interactive tools for this compound:

Reconstitution calculator · Full deep dive · Peptide fundamentals